Thomas W. Flaig, MD, on Choosing Among Many New Bladder Cancer Treatment Options

Posted: Tuesday, April 19, 2022

Thomas W. Flaig, MD, of the University of Colorado Cancer Center, discusses what clinicians need to know when choosing among newer agents: how they differ from earlier standard-of-care regimens, whether they represent improvements, how well they are tolerated, and their durability.